Browse articles from EyeWorld.org related to dry eye. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Nerve growth factor being studied as a possible treatment for Sjogren’s-related dry eye
➤ Investigational RNA therapy doesn’t meet primary endpoint
➤ Phase 1 clinical trial for bioerodible, sustained anti-VEGF delivery
➤ Positive interim data for diabetic retinopathy treatment
➤ Positive results in trial for high-dose aflibercept
➤ Additional Phase 3 trial data for Beovu in DME
➤ ASCRS news and events
➤ FDA approves generic Restasis
➤ Phase 3 trial for novel, preservative-free drug delivery platform
➤ Enrollment complete for Phase 3 blepharitis trial
➤ Enrollment complete for Phase 3 mydriasis reversal study
➤ Path forward for resubmission of drug-device combination product
➤ ‘Immunity and Inflammation in the Anterior Segment of the Eye’ report
➤ ASCRS news and events
➤ FDA approves device to treat MGD
➤ Standalone MIGS device trial begins
➤ Topline results for novel dry eye candidate
➤ Orphan drug designation granted for topical LHON treatment
➤ Positive safety results in Phase 1/2a trial for investigational treatment of wet AMD
➤ Updates on two investigational RNA therapies
➤ ASCRS news and events
➤ Study: Possible therapy to avoid visual problems induced by space travel
➤ Exploratory study finds investigational eye drop for dry eye safe and tolerable
➤ New drug candidate in development to treat dry eye and ocular pain
➤ Results from year 2 of Phase 3 trial of brolucizumab for DME
➤ ASCRS news and events
➤ Small-aperture IOL receives approvable letter from the FDA
➤ Topline results from Phase 2 clinical trial for intracanalicular insert for treatment of dry eye disease
➤ First in-human study to target biomarkers in the eye that identify ALS
➤ Study provides better understanding for bilateral effect after unilateral injection of gene therapy
➤ ASCRS news and events
➤ Positive topline clinical data for investigational topical presbyopia treatment
➤ FDA grants IDE for modular IOL with fluid-filled optic
➤ First participants enrolled in Phase 3 trial for mydriasis reversal
➤ Analysis: Subgroup of dry eye patients benefit from investigational treatment
➤ NDA approved for generic drug designed to treat inflammation, pain
➤ First patient enrolled in Phase 2a study for wet AMD and DME candidate
➤ ASCRS news and events
It’s not the first time the trigeminal nerve pathway or even intranasal delivery received approval as a treatment for dry eye, but clinicians are excited nonetheless about the October 2021 FDA approval of varenicline (TYRVAYA, Oyster Point Pharma), a nasal spray for the signs and symptoms of dry eye disease.
➤ FDA approves first prescription eye drop for presbyopia treatment
➤ Primary endpoint reached in Phase 2 trial for dry eye disease drug
➤ New type of retinal nerve cell discovered
➤ Companies enter collaboration to develop an oral DME, wet AMD treatment
➤ iCare USA acquires remote patient-monitoring tech company
➤ ASCRS news and events
➤ FDA approves suprachoroidal injection for macular edema associated with uveitis
➤ FDA approves first-of-its-kind approach to treat wet AMD
➤ Digital therapeutic for pediatric amblyopia receives FDA premarket approval
➤ Ocular insert for dry eye does not meet Phase 2 primary endpoint
➤ Study: Prozac as a possible treatment for AMD
➤ ASCRS news and events
It’s important for surgeons to be aware of preexisting corneal conditions that could have an impact on outcomes prior to cataract surgery. Several experts spoke about some of the conditions to look for, tests to use, and how to treat before proceeding with cataract surgery.
